These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10942632)

  • 21. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
    Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
    Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men.
    O'Donovan G; Owen A; Kearney EM; Jones DW; Nevill AM; Woolf-May K; Bird SR
    Int J Obes (Lond); 2005 Sep; 29(9):1063-9. PubMed ID: 15925958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency.
    Cummings MH; Christ E; Umpleby AM; Albany E; Wierzbicki A; Lumb PJ; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1997 Jun; 82(6):2010-3. PubMed ID: 9177423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins.
    Albers JJ; Grundy SM; Cleary PA; Small DM; Lachin JM; Schoenfield LJ
    Gastroenterology; 1982 Apr; 82(4):638-46. PubMed ID: 6800869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
    Zhu W; Feng N; Wang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.
    Rasmussen HS; Aurup P; Goldstein K; McNair P; Mortensen PB; Larsen OG; Lawaetz H
    Arch Intern Med; 1989 May; 149(5):1050-3. PubMed ID: 2719498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
    Vahl N; Jørgensen JO; Hansen TB; Klausen IB; Jurik AG; Hagen C; Christiansen JS
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.
    Wildbrett J; Hanefeld M; Fücker K; Pinzer T; Bergmann S; Siegert G; Breidert M
    Exp Clin Endocrinol Diabetes; 1997; 105(6):331-5. PubMed ID: 9439928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
    Eri LM; Urdal P; Bechensteen AG
    J Urol; 1995 Jul; 154(1):100-4. PubMed ID: 7539852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity.
    Rönnemaa T; Marniemi J; Savolainen MJ; Kesäniemi YA; Ehnholm C; Bouchard C; Koskenvuo M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2792-9. PubMed ID: 9709949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.
    Lippi G; Guidi G; Ruzzenente O; Braga V; Adami S
    Scand J Clin Lab Invest; 1997 Oct; 57(6):507-11. PubMed ID: 9350070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
    Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
    Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.